Artificial Blood vs. Real Blood: Key Differences in Composition, Function, and Clinical Use

Comparison

AspectReal BloodArtificial Blood (Oxygen Carriers)
CompositionRBCs, WBCs, platelets, plasma (proteins, electrolytes, hormones)Hemoglobin-based (HBOCs) or perfluorocarbon (PFC) emulsions
O₂ TransportHemoglobin in RBCs (cooperative binding)Free Hb (HBOCs) or dissolved O₂ in PFCs
CO₂ TransportYes (bicarbonate, carbamino)Limited/none
ClottingFull cascade (platelets, factors)None
Immune FunctionWBCs, antibodies, complementNone
Blood TypingRequired (ABO/Rh)Universal (no RBC antigens)
Shelf Life42 days (refrigerated RBCs)1–3 years (room temp for some PFCs)
Volume ExpansionYes (plasma)Yes (carrier fluid)
Regulatory StatusStandard of careInvestigational / limited approval (e.g., Hemopure in SA, Oxyglobin veterinary)

Clinical Context

  • Artificial blood is not a whole-blood substitute—only replaces O₂-carrying capacity temporarily.
  • Used when real blood unavailable (remote, battlefield, shortage) or refused (Jehovah's Witness).
  • HBOCs: Vasoconstriction, renal toxicity, short half-life challenges.
  • PFCs: Require high FiO₂; limited O₂ capacity vs. blood.

Future Directions

Stem-cell-derived RBCs, encapsulated Hb, nanoparticle carriers, and recombinant hemoglobin aim to overcome current limitations. Real blood remains irreplaceable for comprehensive physiologic function.

Blood Disorders - Related Articles